Skip to main content
. 2017 Apr 24;7:46687. doi: 10.1038/srep46687

Figure 5. Metabolomic alterations due to MPs exposure.

Figure 5

Scores plots of PLS-DA for low (A), mid (B) and high (C) doses of MPs-treated groups and control group. (D) Number of differential metabolites among MPs-treated groups. M, 0.1 mg/day; H, 0.5 mg/day.